In addition, several recent studies also showed that perturbation of several ribosomal proteins that induced nucleolar stress in p53-deficient tumor cells could result in tumor cell death, suggesting that nucleolar stress pathway would be an attractive target for cancer therapy although the precise mechanism(s) was unclear [24, 27–29]. The gene discussed is TP53; the disease is cancer.